What questions should I ask my hematologist about the SEQUOIA trial?
Answer:
Consider asking:
- Am I a candidate for zanubrutinib or another BTK inhibitor?
- Do I have any high-risk genetic abnormalities, such as del(17p)?
- What are the potential benefits and risks of long-term BTK inhibitor therapy?
- How often will my disease be monitored?
- What side effects should I watch for?
- How will treatment affect my daily activities and quality of life?
- Will Medicare cover my medication, and what costs should I expect?
- Should I also begin planning for future caregiving or long-term care needs?